1. Home
  2. TECH vs NNN Comparison

TECH vs NNN Comparison

Compare TECH & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • NNN
  • Stock Information
  • Founded
  • TECH 1976
  • NNN 1984
  • Country
  • TECH United States
  • NNN United States
  • Employees
  • TECH N/A
  • NNN N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • NNN Real Estate Investment Trusts
  • Sector
  • TECH Health Care
  • NNN Real Estate
  • Exchange
  • TECH Nasdaq
  • NNN Nasdaq
  • Market Cap
  • TECH 7.8B
  • NNN 7.9B
  • IPO Year
  • TECH 1989
  • NNN N/A
  • Fundamental
  • Price
  • TECH $49.15
  • NNN $42.00
  • Analyst Decision
  • TECH Buy
  • NNN Hold
  • Analyst Count
  • TECH 10
  • NNN 11
  • Target Price
  • TECH $73.44
  • NNN $44.70
  • AVG Volume (30 Days)
  • TECH 2.3M
  • NNN 1.2M
  • Earning Date
  • TECH 05-07-2025
  • NNN 05-01-2025
  • Dividend Yield
  • TECH 0.65%
  • NNN 5.52%
  • EPS Growth
  • TECH N/A
  • NNN N/A
  • EPS
  • TECH 0.83
  • NNN 2.14
  • Revenue
  • TECH $1,208,770,000.00
  • NNN $884,713,000.00
  • Revenue This Year
  • TECH $8.19
  • NNN $4.10
  • Revenue Next Year
  • TECH $8.61
  • NNN $4.32
  • P/E Ratio
  • TECH $59.07
  • NNN $19.63
  • Revenue Growth
  • TECH 4.72
  • NNN 5.40
  • 52 Week Low
  • TECH $46.44
  • NNN $35.80
  • 52 Week High
  • TECH $85.57
  • NNN $49.57
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.74
  • NNN 56.29
  • Support Level
  • TECH $46.35
  • NNN $40.20
  • Resistance Level
  • TECH $54.40
  • NNN $42.50
  • Average True Range (ATR)
  • TECH 2.17
  • NNN 0.72
  • MACD
  • TECH 0.27
  • NNN 0.01
  • Stochastic Oscillator
  • TECH 34.78
  • NNN 78.26

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.

Share on Social Networks: